Dna X Inc (SONM)

Überblick Nachrichten Preisverlauf Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Dna X Inc Stock (SONM) Company Profile

Technology (784)

650-378-8100

4445 EASTGATE MALL, SAN DIEGO, TX

Nächster Verdiensttermin

Neueste SEC-Einreichungen

SONM's Discussions on Twitter

Compare SONM vs MSFT, ORCL, PLTR, CRWD, FTNT

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
SONM Dna X Inc	3.2113	4.66M	27.40M	-17.12M	-24.99M	-106.89
MSFT Microsoft Corp	490.56	3.67T	318.27B	125.22B	72.92B	16.79
ORCL Oracle Corp	160.44	468.13B	67.36B	17.31B	-23.69B	5.8248
PLTR Palantir Technologies Inc	168.94	409.24B	5.22B	2.29B	2.69B	0.8876
CRWD Crowdstrike Holdings Inc	208.77	215.05B	5.09B	-24.89M	1.43B	-0.0471
FTNT Fortinet Inc	157.32	115.54B	7.11B	1.95B	2.44B	2.5883

Dna X Inc Stock (SONM) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2019-10-31	Herabstufung	Oppenheimer	Outperform → Perform
2019-07-18	Eingeleitet	B. Riley FBR	Buy
2019-07-09	Hochstufung	National Securities	Neutral → Buy
2019-06-10	Eingeleitet	National Securities	Neutral
2019-06-04	Eingeleitet	Lake Street	Buy
2019-06-04	Eingeleitet	Oppenheimer	Outperform

Alle ansehen

Dna X Inc Aktie (SONM) Neueste Nachrichten

Finanzdaten der Dna X Inc-Aktie (SONM)

Dna X Inc (SONM)

Dna X Inc Stock (SONM) Company Profile

Compare SONM vs MSFT, ORCL, PLTR, CRWD, FTNT

Dna X Inc Stock (SONM) Upgrades & Downgrades

Dna X Inc Aktie (SONM) Neueste Nachrichten

Press Release Service: Researchers Gain Faster Access to Complex DNA as Integrated DNA Technologies and Ansa Biotechnologies Expand Ordering Platform - CRISPR Medicine News

Sonim Technologies Maintains Nasdaq Compliance Amid Monitoring Period - The Globe and Mail

DNA regained Nasdaq equity compliance but faces one-year mandatory monitor - TradingView

How DNA's Double Helix Structure Was Discovered - Britannica

SONM Q3 2024 Earnings: Loss Narrower Than Expected, Shares Rise 5.8%Profit Recovery Report - vinanet.vn

Sonim Technologies Adopts Cash-Based Director Compensation Structure - The Globe and Mail

DNA awards Substitute Cash Grants to board including CEO Mike Mulica - TradingView

DNA X (SONM) turns to cash after equity plan runs out of shares - Stock Titan

Restriction-enzyme DNA fingerprinting method explained - Britannica

DNA X: Q2 Earnings Snapshot - AOL.com

DNA X, Inc. Reports Second Quarter 2026 Financial Results - The Manila Times

DNA X Q2 EPS improves to $(0.91) from $(14.15) YoY - scanx.trade

DNA X, Inc. 2Q 2026: Revenue $0 EPS $(0.92) — 10-Q Summary - TradingView

SONM: Net income surged to $5.1M as the company pivoted to crypto trading and raised $5M in new capital - TradingView

DNA X (Nasdaq: SONM) profits from phone sale while crypto platform is in the red - Stock Titan

C&F Financial Corporation Announces Quarterly Dividend - The Manila Times

Beam Global Reports Second Quarter 2026 Operating Results - The Manila Times

VVC Exploration Corporation Files Annual Financial Statements - The Manila Times

DNA X raised $5 million after its quarter ended, while its trading platform had no revenue - Stock Titan

DNA (SONM) Quarter in Focus: The Bottom-Line Figure Outpaces Its Comparison in the Latest Session; Market Reaction: The Stock Ends Down 0.60% in Latest TradingGuidance Update - vinanet.vn

12 Information Technology Stocks Moving In Monday's After-Market Session - Benzinga

Aon plc (AON) Holds Near $355.83 as Insurance Broker Consolidates Between Support and ResistanceHigh Volume Node - Vinanet

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Analysts Just Slashed This Year's Revenue Estimates By 22% - simplywall.st

Sonim Technologies delays quarterly filing amid consolidation - TipRanks

DNA X, Inc. (SONM) delays Q2 2026 filing but projects smaller net loss - Stock Titan

SONM Q2'26 Earnings: EPS estimate is 5.22 USD - TradingView

Creative Realities, Inc. (CREX) Stock Price, News, Quote & History - finance.yahoo.com

DNA X, Inc. (SONM) raises $2.5M and targets Nasdaq equity rule compliance - Stock Titan

DNA X, Inc. (SONM) investor Lytton discloses 6.8% stake in latest 13G/A - Stock Titan

DNA X Inc. (SONM) Holds Flat at $3.56 as Range-Bound Trading PersistsChannel Breakout - vinanet.vn

Integrated DNA Technologies Scientists Set New Performance Benchmark for CRISPR Off-Target Nomination - Yahoo Finance

Star Wars Zero Company is a very safe XCOM descendant, but its most interesting parts are found in its Midnight Suns DNA - PC Gamer

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Shares Slammed 36% But Getting In Cheap Might Be Difficult Regardless - 富途牛牛

SONM Q3 2024 Earnings: Narrower-Than-Expected Loss Fails to Lift SharesPost-Announcement Reaction - vinanet.vn

DNA X, Inc. announced that it has received $5.000004 million in funding from DNA Holdings Venture, Inc. - marketscreener.com

DNA X Inc. (SONM) Slips 1.69% as Shares Test Key Support at $3.60Synthetic Short - vinanet.vn

Token Talk Inc. (DNAX) stock price, news, quote and history - Yahoo Finance UK

Ginkgo Bioworks (NYSE: DNA) plans Q2 2026 results presentation and Q&A - Stock Titan

DNA X, Inc. Revenue Breakdown – NASDAQ:SONM - TradingView

VEON Ltd. (VEON) stock price, news, quote and history - Yahoo Finance UK

VEON Ltd. (VEON) Stock Price, News, Quote & History - Yahoo! Finance Canada

YD Bio and EG BioMed Conclude Successful Exhibition at BIO Asia-Taiwan 2026, Highlighting Innovations in Ophthalmology, Oncology Diagnostics, and Clinical Services - The Manila Times

12 Information Technology Stocks Moving In Monday's Pre-Market Session - Benzinga

DNA Sequencing Market Size to Hit USD 57.39 Billion by 2035 - Precedence Research

SAY Q2 2026 Earnings: Significant EPS Miss Raises ConcernsEstimate Uncertainty - dars.gov.et

Sonim Technologies Strengthens Capital Structure With Preferred Financing - The Globe and Mail

12 Information Technology Stocks Moving In Thursday's After-Market Session - Benzinga

DNA X, Inc. Enters Securities Purchase Agreement and Designates Series B Preferred Stock in Major 2026 Transaction - Minichart

DNA X Raises $8.1 Million Via Series B Preferred; $5.0 Million Cash, $3.1 Million Note Cancelled - TradingView

YD Bio Expands U.S. Laboratory Footprint to 46 States, Strengthening DNA-Methylation Early Cancer Detection Operations - The Manila Times

SONM Q3 2024 Earnings: Narrower-Than-Expected Loss, Stock Gains 2.14%Consensus Miss Rate - dars.gov.et

Finanzdaten der Dna X Inc-Aktie (SONM)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie SONM